Victoria Calzada
Montevideo, MO, Uruguay
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Aptamer-Based Immunotheranostic Strategies.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: January 05, 2023
Targeted-Lymphoma Drug Delivery System Based on the Sgc8-c Aptamer.
Journal: Cancers
Published: November 29, 2022
In Vivo Evaluation of Sgc8-c Aptamer as a Molecular Imaging Probe for Colon Cancer in a Mouse Xenograft Model.
Journal: International journal of molecular sciences
Published: December 28, 2021
T908 Polymeric Micelles Improved the Uptake of Sgc8-c Aptamer Probe in Tumor-Bearing Mice: A Co-Association Study between the Probe and Preformed Nanostructures.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 08, 2021
Sequence-dependent structural properties of B-DNA: what have we learned in 40 years?
Journal: Biophysical reviews
Published: August 14, 2021
Metastatic and non-metastatic melanoma imaging using Sgc8-c aptamer PTK7-recognizer.
Journal: Scientific reports
Published: February 03, 2021
Sgc8-c Aptamer as a Potential Theranostic Agent for Hemato-Oncological Malignancies.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: May 15, 2020
Aptamers in Diagnostic and Molecular Imaging Applications.
Journal: Advances in biochemical engineering/biotechnology
Published: December 19, 2019
Derivatizations of Sgc8-c aptamer to prepare metallic radiopharmaceuticals as imaging diagnostic agents: Syntheses, isolations, and physicochemical characterizations.
Journal: Chemical biology & drug design
Published: May 22, 2017
Development of new PTK7-targeting aptamer-fluorescent and -radiolabelled probes for evaluation as molecular imaging agents: Lymphoma and melanoma in vivo proof of concept.
Journal: Bioorganic & medicinal chemistry
Published: September 25, 2016
177Lu-DOTA-Bevacizumab: Radioimmunotherapy Agent for Melanoma.
Journal: Current radiopharmaceuticals
Published: September 02, 2016
Fab(nimotuzumab)-HYNIC-99mTc: Antibody Fragmentation for Molecular Imaging Agents.
Journal: Anti-cancer agents in medicinal chemistry
Published: July 07, 2015
Last Updated: 09/26/2026